4//SEC Filing
Calhoun Lesley Ann 4
Accession 0001610717-24-000099
CIK 0001799448other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:32 PM ET
Size
17.2 KB
Accession
0001610717-24-000099
Insider Transaction Report
Form 4
Calhoun Lesley Ann
See Remarks
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2024-02-27−105,000→ 0 totalExercise: $3.06From: 2022-03-04Exp: 2032-02-04→ Common Stock (105,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-02-27−176,237→ 0 totalExercise: $16.18From: 2021-01-01Exp: 2030-12-01→ Common Stock (176,237 underlying) - Award
Stock Option (Right to Buy)
2024-02-28+51,833→ 51,833 totalExercise: $0.96Exp: 2030-12-01→ Common Stock (51,833 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-02-27−26,250→ 0 totalExercise: $3.06From: 2025-02-04Exp: 2032-02-04→ Common Stock (26,250 underlying) - Award
Stock Option (Right to Buy)
2024-02-28+74,998→ 74,998 totalExercise: $0.96Exp: 2032-02-04→ Common Stock (74,998 underlying) - Award
Stock Option (Right to Buy)
2024-02-28+18,750→ 18,750 totalExercise: $0.96Exp: 2032-02-04→ Common Stock (18,750 underlying)
Footnotes (5)
- [F1]On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 176,237 of the issuer's shares granted to the reporting person on December 1, 2020. In exchange, on February 28, 2024, the reporting person received a replacement option, for 51,833 shares, having an exercise price of $0.96 per share.
- [F2]On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 105,000 of the issuer's shares granted to the reporting person on February 4, 2022. In exchange, on February 28, 2024, the reporting person received a replacement option, for 74,998 shares, having an exercise price of $0.96 per share.
- [F3]On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 26,250 of the issuer's shares granted to the reporting person on February 4, 2022. In exchange, on February 28, 2024, the reporting person received a replacement option, for 18,750 shares, having an exercise price of $0.96 per share.
- [F4]The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary.
- [F5]The shares subject to the option will vest and become exercisable as to 75% of the total number of shares subject to the option on the one year anniversary of the date of the grant and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the reporting person's continued service with the issuer on each such vesting date.
Documents
Issuer
Aligos Therapeutics, Inc.
CIK 0001799448
Entity typeother
Related Parties
1- filerCIK 0001730866
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:32 PM ET
- Size
- 17.2 KB